Abstract:ABSTRACT Background The extent of SARS-CoV-2 exposure and transmission in Mali and the surrounding region is not well understood, although infection has been confirmed in nearly 14,000 symptomatic individuals and their contacts since the first case in March 2020. We aimed to estimate the cumulative incidence of SARS-CoV-2 in three Malian communities, and understand factors associated with infection. Methods Between 27 July 2020 and 29 January 2021, we collected blood samples along with demographic, social, medical and self-reported symptoms information from residents aged 6 months and older in three study communities at two study visits. SARS-CoV-2 antibodies were measured using a highly specific two-antigen ELISA optimized for use in Mali. We calculated cumulative adjusted seroprevalence for each site and evaluated factors associated with serostatus at each visit by univariate and multivariate analysis. Findings Overall, 94.8% (2533/2672) of participants completed both study visits. A total of 50.3% (1343/2672) of participants were male, and 31.3% (837/2672) were aged <10 years, 27.6% (737/2672) were aged 10-17 years, and 41.1% (1098/2572) were aged ≥18 years. The cumulative SARS-CoV-2 exposure rate was 58.5% (95% CI: 47.5 to 69.4). This varied between sites and was 73.4% (95% CI: 59.2 to 87.5) in the urban community of Sotuba, 53.2% (95% CI: 42.8 to 63.6) in the rural town of Bancoumana, and 37.1% (95% CI: 29.6 to 44.5) in the rural village of Donéguébougou. This equates to an infection rate of approximately 1% of the population every three days in the study communities between visits. Increased age and study site were associated with serostatus at both study visits. There was minimal difference in reported symptoms based on serostatus. Interpretation The true extent of SARS-CoV-2 exposure in Mali is greater than previously reported and now approaches hypothetical herd immunity in urban areas. The epidemiology of the pandemic in the region may be primarily subclinical and within background illness rates. In this setting, ongoing surveillance and augmentation of diagnostics to characterize locally circulating variants will be critical to implement effective mitigation strategies like vaccines. Funding This project was funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institute of Biomedical Imaging and Bioengineering, and National Cancer Institute.

Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria

Dendritic cell responses to Plasmodium falciparum in a malaria-endemic setting

Epidemiological overlaps in COVID-19 and malaria within healthcare and community settings of Southern Ghana

Low incidence of COVID-19 case severity and mortality in Africa; Could malaria co-infection provide the missing link?

Malaria and other infections induce polyreactive antibodies that impact SARS‐CoV‐2 seropositivity estimations in endemic settings

COVID-19 in patients presenting with malaria-like symptoms at a primary healthcare facility in Accra, Ghana

COVID-19 and malaria co-infection: a systematic review of clinical outcomes in endemic areas

Covid-19 and Malaria Co-Infection in Imo State, Nigeria: A Descriptive Seroprevalence Study

West African pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2

Heterogeneity of the human immune response to malaria infection and vaccination driven by latent cytomegalovirus infection

Transcriptional Profiles Analysis of COVID-19 and Malaria Patients Reveals Potential Biomarkers in Children

Clinical outcomes and immunological response to SARS-CoV-2 infection among people living with HIV

COVID-19 immune signatures in Uganda persist in HIV co-infection and diverge by pandemic phase

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort Study

Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya

Perturbations in the T cell receptor β repertoire during malaria infection in children: A preliminary study

Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study

Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection

Malaria and COVID-19: commonalities, intersections and implications for sustaining malaria control